Welcome to the e-CCO Library!

OP16 Influence of early life factors on the development of intestinal microbiota of infants born to mothers with and without IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Guedelha Sabino1,2,3, L. Tarassishin1, C. Eisele1, A. Barré1, M. Dubinsky4, J. Stone5, N. Nair1, A. Debebe1, K. Hawkins1, A. Rendon1, J. Hu1, J.F. Colombel3, P. Inga1, J. Torres3,6

Created: Thursday, 30 January 2020, 10:12 AM
OP16: A randomised, multi-centre, double-blind, placebo-controlled study of a targeted release oral cyclosporine formulation in the treatment of mild-to-moderate ulcerative colitis: efficacy results
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Bloom*1, T. Iqbal2, C. Nwokolo3, M. Smith4, D. O’Donoghue5, J. Hall6, B. Dzyngel6

Created: Friday, 22 February 2019, 9:41 AM
OP16: Characterization of the Clinical Features and Outcomes of Paediatric Patients with Isolated Colonic Crohn’s Disease: A Multi-center Study from the Porto Group of ESPGHAN
Year: 2021
Source: ECCO'21 Virtual
Authors: Berger, T.(1);Miin Lee, H.(2);Ramasamy Padmanaban, L.(2);Wine, E.(3);Yerushalmi, A.(4);Hojsak, I.(5);Bronski, J.(6);Serban, D.(7);Yogev, D.(8);Ledder, O.(8);Lionetti, P.(9);Scarrallo, L.(9);Gasparetto, M.(10);Croft, N.(10);Miele, E.(11);Staiano, A.(11);Meredith, J.(12);Aloi, M.(13);Alvisi, P.(14);Urlep, D.(15);Weiss, B.(1);Knudsen, M.(16);Matar, M.(17);Manuel Navas-López, V.(18);Romano, C.(19);Dipasquale, V.(19);Norsa, L.(20);Kolho, K.L.(21);Shamir, R.(17);Shouval, D.(17)
Created: Wednesday, 2 June 2021, 4:12 PM
OP16: Endoscopic and clinical outcomes of upadacitinib in patients with moderately to severely active Crohn's disease by number and type of prior biologics
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Peyrin-Biroulet, L.(1)*;Parkes, G.(2);Rodríguez, C.(3);Siffledeen, J.(4);Wright, J.(5);Broide, E.(6);Ford, S.(7);Lacerda, A.P.(7);Oomen, J.(7);Garrison, A.(7);Berg, S.(7);Rubin, D.T.(8);
Created: Friday, 14 July 2023, 10:43 AM
OP16: The first virtual chromoendoscopy artificial intelligence system to detect endoscopic and histologic remission in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Iacucci, M.(1);Cannatelli, R.(2);Parigi, T.L.(1,3);Buda, A.(4);Labarile, N.(5);Nardone, O.M.(6);Tontini, G.E.(7);Rimondi, A.(7);Bazarova, A.(8);Bhandari, P.(9);Bisschops, R.(10);De Hertogh, G.(10);Del Amor, R.(11);Ferraz, J.G.(12);Goetz, M.(13);Gui, X.(14);Hayee, B.(15);Kiesslich, R.(16);Lazarev, M.(17);Naranjo, V.(11);Panaccione, R.(12);Parra-Blanco, A.(18);Pastorelli, L.(19);Rath, T.(20);Røyset, E.S.(21);Vieth, M.(22);Villanacci, V.(23);Zardo, D.(24);Ghosh, S.(25);Grisan, E.(26,27);
Created: Friday, 11 February 2022, 3:52 PM
OP17 Protein intakes and risk of inflammatory bowel disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Dong1, Y. Mahamat-Saleh2, A. Racine3, P. Jantchou4, S. Chan6, A. Hart5, F. Carbonnel3, M.C. Boutron-Ruault2

Created: Thursday, 30 January 2020, 10:12 AM
OP17: A molecular measure of inflammation in IBD patients based on transcriptional profiles from 2495 intestinal biopsies
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

R. Huang1, H. Irizar2, R. Kosoy3, W-m. Song3, A. Dinarzo3, K. Hao3, J. Rogers4, A. Atreja4, M. Mahajan3, A. Stojmirovic5, J. Perrigoue5, C. Brodmerkel5, S. Plevy5, J. Friedman5, J-F. Colombel4, M. Dubinsky4, B. Sands4, E. Schadt3, A. Kasarskis3, B. Losic3, C. Argmann3, M. Suarez-Farinas1,3

Created: Friday, 22 February 2019, 9:41 AM
OP17: Impact of phenotypic and genetic factors on Crohn’s Disease evolution in a cohort of 13,926 patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Zhang, Q.(1);Fachal, L.(1);Shawky, R.(2);Parkes, M.(2,3,4);Anderson, C.(1);Raine, T.(1,4)
Created: Wednesday, 2 June 2021, 4:12 PM
OP17: Maintenance phase propensity score adjusted effectiveness and persistence at week-52 in biologic-naïve Ulcerative Colitis patients treated with vedolizumab or anti-TNF (VEDO IBD-study)
Year: 2022
Source: ECCO'22
Authors: Plachta-Danielzik, S.(1);di Giuseppe, R.(2);Bokemeyer, B.(3);Efken, P.(4);Mohl, W.(5);Krause, T.(6);Hoffstadt, M.(7);Ehehalt, R.(8);Trentmann, L.(9);Schweitzer, A.(10);Jessen, P.(11);Franzenburg, S.(1);Hartmann, P.(4);Schreiber, S.(12);
Created: Friday, 11 February 2022, 3:52 PM
OP17: Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn's Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Feagan, B.G.(1)*;Horst, S.(2);Dryden, G.(3);Lindsay, J.O.(4);Ferrante, M.(5);Dubenco, E.(6);Lacerda, A.P.(6);Ford, S.(6);Anyanwu, S.I.(6);Zhou, Q.(6);Liu, J.(6);Chen, M.(7);Schreiber, S.(8);
Created: Friday, 14 July 2023, 10:43 AM
OP18 Surgical prevention of anastomotic recurrence by excluding mesentery in Crohn’s disease: The SuPREMe-CD study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

G. Luglio, A. Rispo, N. Imperatore, A. Amendola, F.P. Tropeano, R. Peltrini, F. Castiglione, G.D. De Palma, L. Bucci

Created: Thursday, 30 January 2020, 10:12 AM
OP18: Disease course of Crohn's disease during the first ten years following diagnosis in a prospective European population-based inception cohort – the Epi-IBD cohort
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Wewer, M.D.(1)*;Salupere, R.(2);Kievit, H.A.L.(3);Nielsen, K.R.(4);Midjord, J.(4);Domislovic, V.(5);Krznarić, Ž.(5);Pedersen, N.(6);Kjeldsen, J.(7);Eriksson, C.(8);Halfvarson, J.(8);Talbot, A.(9);Sebastian, S.(9);Goldis, A.(10);Misra, R.(11);Arebi, N.(11);Ilus, T.(12);Oksanen, P.(12,13);Neuman, A.(14);Andersen, V.(15,16,17);Skamnelos, A.(18);Katsanos, K.H.(18);Platon, V.(19);Turcan, S.(19);Borg, B.(20);Ellul, P.(20);Kupcinskas, J.(21);Kiudelis, G.(21);Yzet, C.(22);Fumery, M.(22);Kaimakliotis, I.P.(23);Lorenzon, G.(24);D'Inca, R.(24);Hernandez, V.(25,26);Fernandez, A.(27);Langholz, E.(28);Munkholm, P.(29);Burisch, J.(1);
Created: Friday, 14 July 2023, 10:43 AM
OP18: Efficacy and safety of filgotinib for the treatment of perianal fistulizing Crohn’s Disease: Results from the phase 2 DIVERGENCE 2 study
Year: 2022
Source: ECCO'22
Authors: Reinisch , W.(1);Colombel , J.F.(2);D’Haens , G.R.(3);Rimola , J.(4);DeHaas-Amatsaleh , A.(5);McKevitt , M.(6);Ren , X.(6);Serone , A.(6);Schwartz , D.A.(7);Gecse , K.B.(3);
Created: Friday, 11 February 2022, 3:52 PM
OP18: Proactive adalimumab trough measurements increase corticosteroid-free clinical remission in paediatric patients with Crohn’s disease: the paediatric Crohn’s disease adalimumab-level-based optimisation treatment (PAILOT) trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Assa*1, M. Matar2, D. Turner3, E. Broide4, B. Weiss5, O. Ledder6, A. Guz Mark2, F. Rinawi2, S. Cohen7, C. Topf Olivestone8, R. Shaoul9, B. Yerushalmi10, R. Shamir2

Created: Friday, 22 February 2019, 9:41 AM
OP18: Treatment of perianal fistulas in Crohn’s Disease: Surgical closure after anti-TNF induction treatment versus anti-TNF without surgery (PISA II) - A patient preference RCT
Year: 2021
Source: ECCO'21 Virtual
Authors: Meima - van Praag, E.(1);van Rijn, K.(2);Snijder, A.(3);Wasmann, K.(4);Stoker, J.(2);D'Haens, G.(3);Gecse, K.(3);Gerhards, M.(5);Jansen, J.(6);Pronk, A.(7);van Tyl, S.(8);Zimmerman, D.(9);Bruin, K.(10);Spinelli, A.(11);Danese, S.(12);van der Bilt, J.(13);Mundt, M.(14);Bemelman, W.(1);Buskens, C.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
OP19 Perinatal factors do not affect paediatric inflammatory bowel disease risk: A Scottish Nationwide Cohort study using administrative health data 1981–2017
Year: 2020
Source:

ECCO'20 Vienna

Authors:

C. Burgess1,2, C. Schnier3, I. Chalmers4, R.K. Russell5, R. Hansen5, P. Henderson1,2, R. Wood6,7, D.C. Wilson1,2

Created: Thursday, 30 January 2020, 10:12 AM
OP19: Classifying perianal fistulising Crohn’s Disease: An expert-consensus to guide decision-making in daily practice and clinical trials
Year: 2022
Source: ECCO'22
Authors: Geldof, J.(1);Iqbal, N.(2);LeBlanc, J.F.(3);Sawyer, R.(4);Buskens, C.(5);Bemelman, W.(5);Gecse, K.(6);Lundby, L.(7);Lightner, A.L.(8);Danese, S.(9);Spinelli, A.(10);Carvello, M.(10);Faiz, O.(11);Warusavitarne, J.(11);Lung, P.(12);De Looze, D.(13);D’Hoore, A.(14);Vermeire, S.(15);Hart, A.(3);Tozer, P.(16);
Created: Friday, 11 February 2022, 3:52 PM
OP19: Corticosteroid response rectal gene signature and associated microbial variation in treatment naïve ulcerative colitis
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

Y. Haberman*1,2, R. Karns2, P. Dexheimer2, M. Schirmer3, T. Braun1, M. Collins2, A. Mo4, M. Rosen2, N. Gotman5, PROTECT Study group, S. Kugathasan6, T. D. Walters7, G. Gibson4, S. Davis Thomas5, C. Huttenhower8, R. J. Xavier9, J. S. Hyams10, L. A. Denson2

Created: Friday, 22 February 2019, 9:41 AM
OP19: Disease course and treatment outcomes of early resected Crohn's Disease patients: A Danish nationwide cohort study from 1997 to 2015
Year: 2021
Source: ECCO'21 Virtual
Authors: Sarikaya, M.(1);Zhao, M.(2);Bendtsen, F.(1,2);Burisch, J.(2)
Created: Wednesday, 2 June 2021, 4:12 PM
OP19: Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Fiorino, G.(1)*;
Created: Friday, 14 July 2023, 10:43 AM